Clicky

all4insure.ru

    Intelligence » Pneumonia » Last Year

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    Saturday, September 02, 2017 -- The Partner State Key Laboratory of Chirosciences at the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) discovered a newly emerged superbug, hyper-resistant and hypervirulent Klebsiella pneumoniae, which may cause untreatable and fatal infections in relatively healthy individuals and will pose enormous threat to human health. Prof. Chen Sheng, […] The post Newly emerged superbug, hyper-resistant and hypervirulent Klebsiella pneumoniae discovered appeared first on Outbreak News Today.

    Friday, November 17, 2017 -- It took Stanford AI researchers just a month to beat radiologists at the pneumonia game

    Monday, August 28, 2017 -- Halotherapy, breathing in salty air inside a salt mine or a salt chamber, has become a health trend for those with respiratory ailments. However, the science behind the practice is unproven. The post Can Inhaling Salty Air Cure Respiratory Illness? appeared first on Futurism.

    Monday, October 16, 2017 -- All mice with cystic fibrosis that received iclaprim for a pneumonia infection survived, according to a study. Motif Bio reported the finding, which involved the Staphylococcus aureus bacteria, and the results of another preclinical-trial study at the IDWeek 2017 conference in San Diego, Oct. 4-8. Iclaprim is designed to kill bacteria that develop resistance to other antibiotics. Iclaprim has shown punch against a […] The post All Mice with CF That Received Iclaprim for Pneumonia Survived, Study Shows appeared first on Cystic Fibrosis News Today.

    Tuesday, May 16, 2017 -- Coming down with the flu, bronchitis or pneumonia can dramatically raise the risk of a heart attack -- up to 17-fold -- in the days and weeks following the infection, researchers say.

    Sunday, May 21, 2017 -- Approximately one in four (22.1%) adults prescribed an antibiotic in an outpatient setting (such as a doctor’s office) for community-acquired pneumonia does not respond to treatment, according to a new study presented at the 2017 American Thoracic Society International Conference. “Pneumonia is the leading cause of death from infectious disease in the United States, so […] The post Antibiotics don’t work in nearly 1 in 4 pneumonia cases: Study appeared first on Outbreak News Today.

    Tuesday, August 22, 2017 -- MUMBAI (Reuters) - India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.

    Wednesday, July 05, 2017 -- Combining genetic analysis and machine learning can improve the identification value of biopsies used to detect pneumonia that progressively scars lungs — a classic marker of pulmonary fibrosis — without doctors having to resort to surgery, according to a study. The findings apply to the transbronchial biopsies, or TBBs, that doctors use to diagnose patients with usual […] The post Genomic Classifier Can Improve Accuracy of Test for Pulmonary Fibrosis-linked Pneumonia, Study Reports appeared first on Pulmonary Fibrosis News.

    Wednesday, August 02, 2017 -- Hospital admission for pneumonia or sepsis could increase the risk of cardiovascular disease by more than sixfold in the first year, study finds.

    Tuesday, August 29, 2017 -- (Reuters Health) - Children treated for respiratory illnesses in the emergency department often have a chronic cough that lingers for weeks after they go home from the hospital, an Australian study suggests.

    Tuesday, May 23, 2017 -- Approximately one in four (22.1 percent) adults prescribed an antibiotic in an outpatient setting (such as a doctor's office) for community-acquired pneumonia does not respond to treatment, according...

    Monday, July 31, 2017 -- Objectives: To determine the proportion of patients with documented bacterial aspiration pneumonia among comatose ICU patients with symptoms suggesting either bacterial aspiration pneumonia or non-bacterial aspiration pneumonitis. Design: Prospective observational study. Setting: University-affiliated 30-bed ICU. Patients: Prospective cohort of 250 patients admitted to the ICU with coma (Glasgow Coma Scale score ≤ 8) and treated with invasive mechanical ventilation. Interventions: None. Measurements and Main Results: The primary outcome was the proportion of patients with microbiologically documented bacterial aspiration pneumonia. Patients meeting predefined criteria for aspiration syndrome routinely underwent telescopic plugged catheter sampling during bronchoscopy before starting probabilistic antibiotic treatment. When cultures were negative, the antibiotic treatment was stopped. Of 250 included patients, 98 (39.2%) had aspiration syndrome, including 92

    Friday, November 03, 2017 -- Lisa Schnirring | News Editor | CIDRAP NewsNov 03, 2017Using just 1 drug instead of 2 could go a long way in curbing azithromycin use.

    Monday, August 21, 2017 -- Researchers from the University of Mississippi report a case of an HIV-positive man with pneumonia due to MRSA who was treated with dalbavancin.

    Wednesday, September 27, 2017 -- Lisa Schnirring | News Editor | CIDRAP NewsSep 27, 2017Only 54% of US workers with asthma had received the recommended pneumococcal vaccine.

    Tuesday, January 09, 2018 -- A recent study suggests that the new antibiotic combination ceftazidime-avibactam may be a useful alternative for treating hospital-acquired pneumonia.

    Friday, August 18, 2017 -- The results of a new study reveal increased risk of cardiovascular disease in adults previously hospitalized for pneumonia or sepsis.

    Tuesday, May 30, 2017 -- Research presented at the 2017 American Thoracic Society International Conference reports that treatment with antibiotics failed in 1 in 4 adult patients who present with community-acquired pneumonia in the outpatient setting.

    Wednesday, December 27, 2017 -- Pfizer’s pneumonia vaccine patent has come under legal challenge in India.

    Tuesday, October 10, 2017 -- Prolonged antibiotic use opens the door to the development of antibiotic resistance, superinfections, and the risk of Clostridium difficile infections.

    Related pages


    ingredients of coronaginseng honey benefitsapitusreviews of latisseprospan for babiesmisotac tabletsdimethylpolysiloxane usesvoluven solutionsenokot contraindicationsfebuget 40 uric acidjoshilaneela thothanice pak locationsfuramist side effectsapominocyclinedinoprostone side effectsavil injectionoblas oilaptivate syrup compositionsodium glycinatelagaflex dosagederiva aqueous gel reviewswhat is hyospasmol used forativan 1mg tabletquinax alconoptalgin dosageunivestin ingredientsfullers earth cream usesdanzen drugside effects of flunil 20seratomadaktacort cream reviewsstrovite plusvinceeponstantpolysporin indiaagitated psychosisside effects of l-glutathionewhat is voluven used forlexam 10 side effectslavender oil contraindicationsqtenneurobion plus useswhere to buy sodium boratesodium cocyl glutamatesensa medicyne creem/tablets in hindipenlac dosagedecongestant or expectorantbecosules dosagedipyridamole package insertwhat is non pyrogenicprazolamside effects of yamini tabletsmetformin contraindicationrifinah side effectscinaronlipotropic adjunct side effectsultravex ointmentdaflon 500protonix used fornephrocaps druglactrincitro sodatobradex alconzyrcold syrup side effectslibrium medicationprobiotic vsl 3 side effectstab voverandicloflex sodiumglyadebenzyl benzoate mechanism of actionnucoxia 120vitamin b50 side effectsleucorinskin derm creamside effects of olbas oilsenna coloxyl